产品中心Cell Resources
联系我们CONTACT US
- 400-999-210024小时服务热线
产品概述
产品简介
HCC1806细胞专用培养基由普诺赛技术团队精心优化,经过长期测试,本产品可保持HCC1806细胞最佳的生长状态。本产品中已包含HCC1806细胞生长所需的各种成分,无需添加任何成分,可直接用于HCC1806细胞的体外培养。本产品仅供进一步科研使用,不得用于诊断、治疗、临床、家庭及其它用途。
产品说明
产品形态 | 液体 |
产品浓度 | 1x |
产品规格 | 125mL×4 |
培养基成分 | RPMI-1640(PM150110)+10% FBS(164210-50)+1% P/S(PB180120) |
细菌检测 | 阴性 |
真菌检测 | 阴性 |
支原体检测 | 阴性 |
细胞生长实验 | 细胞生长良好,形态正常 |
内毒素含量(EU/mL) | ≤3 |
储存条件 | 2-8℃,避光储存 |
运输条件 | 冰袋冷藏运输 |
有效期 | 6个月 |
注意事项
参考文献
-
The dePARylase NUDT16 promotes radiation resistance of cancer cells by blocking SETD3 for degradation via reversing its ADP-ribosylation (2024-01-22)
作者:Weijun Wu:1.Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China; Department of Oncology Radiotherapy, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China. ; Wenjing Wu:1.Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China; Department of Breast Oncology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China. ; Yingshi Zhou:1.Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, G
期刊:The dePARylase NUDT16 promotes radiation resistance of cancer cells by blocking SETD3 for degradation via reversing its ADP-ribosylation
影响因子 :4.8
引用产品: MCF 10A 细胞 , HCC1806 细胞 , HCC1937 细胞 , MDA-MB-468 细胞 , BT-20 细胞 , Hs 578T 细胞 , MDA-MB-436 细胞 , MCF 10A细胞专用培养基 , HCC1806细胞专用培养基 , HCC1937细胞专用培养基 , MDA-MB-468细胞专用培养基 (L15) , BT-20细胞专用培养基 , Hs 578T细胞专用培养基 , MDA-MB-436细胞专用培养基 (L15)
-
Leveraging senescence-oxidative stress co-relation to predict prognosis and drug sensitivity in breast invasive carcinoma (2023-08-04)
作者:Yinghui Ye:1.Department of Laboratory Medicine, Peking University Shenzhen Hospital, Shenzhen, China. ; Yulou Luo:1.Department of Breast Surgery, Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, China. ; Tong Guo:1.Department of Laboratory Medicine, Peking University Shenzhen Hospital, Shenzhen, China. ; Chenguang Zhang:1.Department of Breast Surgery, Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, China. ; Yutian Sun:1.Department of Medical Oncology, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China. ; Anping Xu:1.Department of Laboratory Medicine, Peking University Shenzhen Hospital, Shenzhen, China. ; Ling Ji:1.Department of Laboratory Medicine, Peking University Shenzhen Hospital, Shenzhen, China. ; Jianghua Ou:1.Department of Breast Surgery, Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, China. ; Shang Ying Wu:1.Depa
期刊:Leveraging senescence-oxidative stress co-relation to predict prognosis and drug sensitivity in breast invasive carcinoma
DOI:10.3389/fendo.2023.1179050
影响因子 :5.2
引用产品: MCF7 [MCF-7] 细胞 , BT-20 细胞 , MDA-MB-231 细胞 , HCC1806 细胞 , HCC1937 细胞 , MCF7 [MCF-7]细胞专用培养基 , BT-20细胞专用培养基 , MDA-MB-231细胞专用培养基 (L15) , HCC1806细胞专用培养基 , HCC1937细胞专用培养基
FAQs
Q:{{item.question}}
A:
产品资料
识别码示意图